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The stress hormone, epinephrine, is produced predominantly by adrenal chromaﬃn cells and its biosynthesis is regulated by the
enzyme phenylethanolamine N-methyltransferase (PNMT). Studies have demonstrated that PNMT may be regulated hormonally
via the hypothalamic-pituitary-adrenal axis and neurally via the stimulation of the splanchnic nerve. Additionally, hypoxia has
been shown to play a key role in the regulation of PNMT. The purpose of this study was to examine the impact of reactive oxygen
species (ROS) produced by the hypoxia mimetic agent CoCl2, on the hormonal and neural stimulation of PNMT in an in vitro
cell culture model, utilizing the rat pheochromocytoma (PC12) cell line. RT-PCR analyses show inductions of the PNMT intron-
retaining and intronless mRNA splice variants by CoCl2 (3.0- and 1.76-fold, respectively). Transient transfection assays of cells
treatedsimultaneouslywithCoCl2 andthesyntheticglucocorticoid,dexamethasone,showincreasedpromoteractivity(18.5-fold),
while mRNA levels of both splice variants do not demonstrate synergistic eﬀects. Similar results were observed when investigating
the eﬀects of CoCl2-induced ROS on the neural stimulation of PNMT via forskolin. Our ﬁndings demonstrate that CoCl2-induced
ROS have synergistic eﬀects on hormonal and neural activation of the PNMT promoter.
1.Introduction
Epinephrine is synthesized by the catecholamine biosyn-
thetic enzyme phenylethanolamine N-methyltransferase
(PNMT, EC 2.1.1.28) [1]. PNMT is a critical determinant of
epinephrine production in adrenal chromaﬃn cells during
acute and chronic stress. Stress contributes to the pathophys-
iology of many diseases and epinephrine and glucocorticoids
(cortisol and corticosterone) are the major stress hormones
that initiate the biological responses permitting the organ-
ism to cope with adverse physiological, psychological, and
environmental stress [2]. All catecholamine biosynthetic
enzymes including PNMT are stress responsive; however,
their responses are stressor-speciﬁc, dependent on stress
intensity, duration, and number of repeated exposures [3, 4].
The PNMT gene has been shown to be both hormonally
and neurally regulated through activation of the hypotha-
lamic-pituitary-adrenal (HPA) axis and the sympathoad-
renal (SA) system [5]. Both activation mechanisms exert
transcriptional and post-transcriptional inﬂuences on the
PNMT gene [6–8]. Hormonal activation of the PNMT gene
is dependent on extremely high concentrations of glucocor-
ticoids which induce transcriptional changes via glucocor-
ticoid response elements (GREs) upstream of PNMT tran-
scription initiation site [9]. The activation of PNMT through
the sympatho-adrenal system can occur via the release of
acetylcholine and PACAP from the splanchnic nerve [5].
Neurotransmitters such as acetylcholine, serotonin, and the
peptide neurotransmitter PACAP have been shown to induce
PNMT via the protein kinase A (PKA) and protein kinase C2 Oxidative Medicine and Cellular Longevity
(PKC) pathways [10, 11]. In addition, both acetylcholine and
PACAPactivatesignalingcascadesthatregulatetranscription
factors expressed exclusively in adrenergic cells such as the
early growth response transcription factor 1 (Egr-1) and
promote PNMT transcription [12].
Previous studies have shown that hypoxia is a potent
stressor involved in the regulation of PNMT [13]. Cells
experiencing lowered O2 levels (hypoxia) undergo a vari-
ety of biological responses in order to adapt to these
unfavorable conditions [14]. Hypoxia, or decreased oxygen
concentration, activates a variety of complex pathways at
both the cellular and organism level with the ultimate aim
of reinstating oxygen homeostasis. Although physiological
responses to hypoxia have been appreciated for a long time,
the molecular processes activated within the cells are still
under investigation. However, this area has been greatly
advanced by the discovery of a class of transcription factors
that respond to hypoxia, HIF (hypoxia inducible factors)
[15]. The HIFs stimulate a variety of genes, including PNMT
[16–19].
Hypoxic conditions can also give rise to the produc-
tion of reactive oxygen species (ROS) as well as reactive
nitrogen species (RNS). The production of ROS/RNS is
referred to as oxidative stress, a condition in which the
balance between production and disposal of ROS/RNS is
altered [20]. Several studies report that exposing cells or
tissues to hypoxia increases oxidative stress and that this
increase is generated by the mitochondria [21]. The ROS
and RNS that arise from hypoxic conditions can lead to
ﬁxed changes in signal transduction and gene expression,
resulting in disease development and progression [22].
ROS/RNS function as speciﬁc signaling molecules to trigger
the activation of speciﬁc transduction pathways and damage
to cellular components. ROS/RNS mediate these eﬀects
through the activation of speciﬁc transcription factors to
control the transcription of a range of target genes. Several
studies demonstrate that the delivery of CoCl2 to cultured
cells can mimic hypoxic responses, including the increased
production of ROS [22, 23]. Additionally, exposure of PC12
cellstohypoxia-mimickingconcentrationsofCoCl2 hasbeen
shown to upregulate the transcription of HIF1α and cause
mitochondrial DNA damage [24].
The purpose of this study is to understand the role of
oxidative stress arising from a hypoxic environment, and its
eﬀectonthehormonalandneuralstimulationofPNMT.The
eﬀects of oxidative stress on PNMT and thereby epinephrine
have not previously been shown and will allow for a better
understanding of the impact of oxidative stress on the
transcriptional machinery involved in the regulation of the
PNMT gene. This, in turn, will allow us to better understand
how epinephrine production is controlled via PNMT and
its role as a neuroendocrine regulator in various disease
states. The present study shows that under mimetic hypoxic
stressgeneratedviaCoCl2,PC12cellselicittheproductionof
ROS and promote PNMT gene transcription. Additionally,
oxidative stress arising from the hypoxia mimetic agent
CoCl2 further promotes the transcription of the PNMT
gene when combined with hormonal as well as with neural
stimulation.
2.MaterialsandMethods
2.1. Cell Culture. PC12 cells (from D. O’Connor, UCSD, San
Diego, CA, USA) were cultured in DMEM supplemented
with 5% equine serum, 5% bovine serum and gentamycin
sulphate (50 μg/mL). All cells were maintained in a humid-
iﬁed incubator at 37◦Ci na na t m o s p h e r eo f5 %C O 2–
95% air and grown to 80–90% conﬂuency before being
passed or used in an experiment. Hypoxia was achieved
by displacement of oxygen from 21% to 5% with nitrogen
gas. Prior to experimentation, cells were transferred to
DMEM containing charcoal-treated serum. For transfection
studies, cells were plated in 24-well tissue culture plates at
a density of 4-5 × 105 cells/well. For total RNA extraction,
cells were grown in 100-mm culture dishes to a density
of 5 × 105–1.8 × 106 cells per dish. Following seeding,
cells were allowed to adhere to plates for 16–24h prior
to beginning experiments. Cells were then drug treated
with CoCl2 (200μM), dexamethasone (1μM), N-acetyl-
L-cysteine (5mM) (Sigma-Aldrich, St. Louis, MO, USA),
forskolin (10μM) (LC Laboratories, Woburn, MA, USA) or
the combination of each agonist with CoCl2 for times and at
concentrations speciﬁed in the ﬁgure legends.
2.2. Measurement of Intracellular ROS by Flow Cytometry.
Production of intracellular ROS was quantiﬁed using the
CM-H2DCFDA method (Invitrogen, C6827). Following
treatments, culture media was collected in 15mL conical
tubes. Cells were then scraped with 1mL cold phosphate-
buﬀered saline (PBS, pH 7.4) and added to the conical tubes,
centrifuged at 1,000rpm (5min, 4◦C) and washed with cold
PBS (pH 7.4). Cell pellets were resuspended in 1mL 2.5μM
detection reagent, transferred to 1.5mL centrifuge tubes and
incubated at 37◦C for 30mins. Cells were then pelleted,
resuspendedin1mLculturemedium,andincubatedat37◦C
for 30min. Following incubation, cells were centrifuged at
2,400rpm (8min, 4◦C) and washed with PBS (pH 7.4). Cells
were then resuspended in 1mL PBS (pH 7.4) and analyzed
using a ﬂow cytometer (BD Biosciences, FACS Canto II).
In brief, cells were excited with 488/10nm, and their
ﬂuorescence emission was recorded in the 530/30nm range.
The amount of intracellular ROS within cell populations
is directly proportional to their mean ﬂuorescent emission.
Fluorescent emission values from 10,000 independent events
were used to compute a mean ﬂuorescent value for each
treatment group. Treatment groups were then compared to
stained control cells to determine the relative fold change of
intracellular ROS.
2.3. Measurement of Nitric Oxide. Extracellular nitric oxide
levels were quantiﬁed using the Nitric Oxide Analyzer
(model 280, Sievers Instruments, Boulder, Colorado) [25].
Following treatments, culture media was collected in 1.5mL
centrifuge tubes. In brief, 10μL of media from each treat-
mentwasinjectedintoahigh-sensitivitydetector.Thisdevice
uses the chemiluminescent method to determine media
content of nitrite (NO2
•) and nitrate (NO3
•), the stable
oxidation products of NO. The nitroso-compounds NO2
•
and NO3
• are reduced to NO by exposure to vanadiumOxidative Medicine and Cellular Longevity 3
chloride which is then determined from the gas-phase
chemiluminescent reaction between NO and ozone. Emis-
sion from electronically excited nitrogen dioxide is in the red
and near red infrared region of the spectrum and is detected
by a thermoelectrically cooled, red-sensitive photomultiplier
tube. A calibration curve using sodium nitrate standards was
used to calculate concentrations for the samples.
2.4. RT-PCR. PC12 cells (1.6 × 106 cells/mL) were seeded
into 60-mm culture dishes in modiﬁed DMEM, and treated
as previously described. Cells were harvested and lysed
in 500μL Tri-Reagent (Sigma Aldrich Canada Ltd) and
total RNA isolated per manufacturer’s protocol. Total RNA
pellets were resuspended in diethylpyrocarbonate-treated
nuclease-free water and concentrations determined using
spectrophotometric measurements of absorbance at 260nm
(NanoDrop; Nanodrop Technologies, Wilmington, DE).
2μg of total RNA was treated with DNase I (Sigma
Aldrich Ltd.) following manufacturer’s protocol, and cDNA
subsequently synthesized using 100U Revert Aid Moloney
Murine Leukemia Virus reverse transcriptase enzyme as
per manufacturer’s protocol (Fermentas, Burlington, ON,
Canada).PCRwasperformedin25μLreactionvolumescon-
taining 78ng of cDNA, using 50U GoTaq Flexi DNA poly-
merase (Promega) containing 200μMo fd N T P s ,1 . 5 m M
MgCl2, and 25ng of forward and reverse primer sequences
speciﬁc for the following genes: PNMT and glyceraldehyde
3-phosphate dehydrogenase (GAPDH) (Table 1).
PCR products (10μL) were electrophoresed on a 1.5%
agarose gel in 40mM Tris-acetate and 2mM EDTA buﬀer
(pH 8), stained with ethidium bromide, documented using
the Chemidoc XRS (Biorad) imaging system and densito-
metric analysis performed using the Quantity One software
(Biorad).
2.5. Plasmids. The wild-type PNMT promoter-luciferase
reporter gene construct pGL3RP893 was generated as pre-
viously described [7, 26, 27]. Competent E. coli cells were
transformed with plasmid DNA to generate the PNMT
promoter-luciferase reporter gene construct, and DNA
plasmids were subsequently puriﬁed using the Invitrogen
PureLink HiPure Plasmid DNA puriﬁcation kit (Invitro-
gen Invitrogen Life Technologies Corp. Burlington, ON,
Canada).
2.6. Transient Transfection Assays. Transient transfections
were performed using the polyethylenimine (PEI) method
as previously described [7, 28]. PC12 cells grown in 24-well
tissue culture plates were transfected with 1.0μg of wild-
type promoter-luciferase reporter gene construct using 5μL
of 1X polyethylenimine to transfect 1μg of plasmid with an
incubation period of 3h. After transfection, the cells were
washed with phosphate buﬀered saline (PBS, pH 7.4) and
maintained in culture medium for 24h, followed by drug
treatment.
2.7. Luciferase Assays. Cell culture medium was removed,
the cells rinsed twice with PBS and then lysed with 100μL
lysis buﬀer (1.25mM Tris-phosphate, pH 7.8, 2mM DTT,
2mM 1,2-diaminocyclohexane-N,N,N
 ,N
 -tetraacetic acid
10% Glycerol and 1% Triton X-100) and subjection to a
freeze-thaw cycle. Cell lysates were centrifuged at 3000g
for 10min, and 20μL of supernatant assayed for luciferase
activity as previously described by Tai and Wong using a
microplate luminometer (Fluostar Optima BMG Labtech
Nepean, ON, Canada) [7]. Total protein in the lysates was
determinedbythemethodofBradford(1976),andluciferase
activity expressed as optical density units per μgo fp r o t e i n
[29].
2.8. Data Analysis. All data are presented as the mean ±
SEM. Experiments were repeated at least three times and
statistical signiﬁcance between experimental and control
groups was determined by one-way ANOVA followed by a
posthoc comparison using the Student-Newman-Keuls for
multiple comparisons test. Results were considered statisti-
cally signiﬁcant with a P<0.05.
3. Results
3.1. Eﬀect of CoCl2 and Hypoxia on Intracellular ROS and
NOLevels. PC12cellstreatedwith200μMC oCl 2 orexposed
to 5% oxygen for 24h increased intracellular ROS levels
2.3-fold (P<0.01) and 1.7-fold (P<0.05), respectively,
compared to control (Figure 1(a)). Conversely, PC12 cells
treatedwithCoCl2 or exposed to 5% oxygen for 24h showed
asigniﬁcantdecreaseof3μM(P<0.05)and6μM(P<0.01)
in intracellular NO levels, respectively, compared to control
(Figure 1(b)).
3.2. Eﬀect of NAC on CoCl2 I n d u c e dG e n eE x p r e s s i o na n d
on Intracellular ROS and NO Levels. CoCl2 treatment sig-
niﬁcantly increased PNMT intron-retaining and intronless
mRNA levels by 3.0-fold (P<0.01) and 1.76 (P<0.01)
respectively, compared to untreated control. To assess
whether mRNA induction of PNMT by CoCl2 could be
abolished by antioxidant treatment, cells were pretreated
with 5mM NAC for 30min prior to CoCl2 delivery
(Figures 2(a), 2(b),a n d2(c)). Cells pretreated with NAC
prior to CoCl2 delivery showed decreased PNMT intron-
retaining and intronless mRNA levels by 2.0-fold (P<0.01)
and 0.9-fold (P<0.01), respectively, compared to CoCl2
controls (Figures 2(b) and 2(c)).
To conﬁrm the scavenging of ROS by NAC during
CoCl2 stress, intracellular ROS levels were measured after
24h. NAC treatment signiﬁcantly reduced basal levels of
intracellular ROS by 0.5-fold (P<0.05) and signiﬁcantly
r e d u c e dl e v e l so fC o C l 2-generated ROS by 1.8-fold (P<
0.001) compared to control (Figure 2(d)). Cells treated with
5m MN A Cr e d u c e db a s a lN Ol e v e l sb y1 5μM( P<0.001),
while cells treated with CoCl2 alone signiﬁcantly reduced
NO levels by 3.4μM compared to control. Cells pretreated
with NAC prior to CoCl2 treatment showed no signiﬁcant
change in NO levels compared to cells treated with CoCl2
alone (Figure 2(e)).4 Oxidative Medicine and Cellular Longevity
Table 1: The following primer sets were used for PNMT and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Gene Species Accession number Primer sequence (5 –3 ) Amplicon No. of cycles Annealing temp. (◦C)
PNMT R. norvegicus X75333 CAGACTTCTTGGAGGTCAACCG
422bp, 312bp 35 58 (forward)
AGCAGCGTCGTGATATGATAC
(reverse)
GAPDH R. norvegicus BC059110 ATGGTGGTGCTGAGTATGTCG
475bp 21 58 (forward)
CATGTCAGATCCACAACGGATAC
(reverse)
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Figure 1: Eﬀect of CoCl2 and hypoxia exposure on free radicals. Levels of intracellular ROS (a) and extracellular NO (b) were measured in
PC12cellsfollowing24hexposuretoeither200μMCoCl 2 or5%oxygenat37◦C.DatapresentedasrelativefoldchangeorNOconcentration
± SEM from a minimum of three independent experiments. Signiﬁcance deﬁned as ∗P<0.05; ∗∗P<0.01.
3.3. Eﬀect of ROS on the Hormonal Regulation of the PNMT
Gene. TodeterminewhethertheintracellularROSgenerated
by CoCl2 could potentiate the glucocorticoid activation of
the PNMT gene, transient transfection assays and RT-PCR
were performed on cells treated with 200μMo fC o C l 2,
1μM of dexamethasone and the combination of both
drugs for 24h. Transient transfection assays with a PNMT
promoter-luciferase reporter gene construct harbouring the
proximal −893bp (pGL3RP893), revealed activation of the
PNMT promoter following dexamethasone treatment (2.9-
fold; P<0.05), CoCl2 treatment (3.7-fold, P<0.01),
and the combination treatment (18.5-fold; P<0.001)
(Figure 3(a)). RT-PCR demonstrated increased expression of
the intron-retaining splice variant of PNMT when treated
with CoCl2 (3.0-fold; P<0.001) and decreased expression
when treated in combination with dexamethasone (0.8-fold;
P<0.001) (Figure 3(c)). Further, RT-PCR showed increased
expression of the intronless splice variant of PNMT when
treated with CoCl2 (2.7-fold; P<0.05) compared to control
and decreased expression when treated in combination
with dexamethasone (2.7-fold; P<0.01), compared to
treatment with dexamethasone alone (3.5-fold; P<0.001)
(Figure 3(d)).
3.4. Eﬀect of ROS on the Neural Regulation of the PNMT
Gene. To determine whether intracellular ROS generated via
CoCl2 treatment could potentiate the cholinergic activation
of the PNMT gene, transient transfection assays and RT-
PCR were performed on cells treated with 200μMo fC o C l 2,
10μM of forskolin and the combination of both drugs for
24h. Transient transfection assays with a PNMT promoter-
luciferase reporter gene construct harbouring the proximal
−893bp (pGL3RP893), revealed activation of the PNMT
promoter following forskolin treatment (2.4-fold; P<0.05),
CoCl2 treatment (3.7-fold, P<0.01), and the combination
treatment (12.1-fold; P<0.001) (Figure 4(a)). Combina-
tion treatment of forskolin and CoCl2 showed a decrease in
intron-retaining PNMT mRNA levels (1.0-fold, P<0.001)
compared to CoCl2 treatment alone (Figures 4(b) and 4(c)).
RT-PCR for the PNMT intronless splice variant demon-
strated increased expression when treated with forskolin
(2.0-fold, P<0.01), compared to control (Figures 4(b)Oxidative Medicine and Cellular Longevity 5
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Figure 2: Eﬀect of NAC pretreatment on levels of PNMT mRNA, intracellular ROS, and extracellular NO in PC12 cells treated with
200μMC o C l 2 for 24h at 37◦C. (a) Representative image (n = 3) of PNMT (intron-retaining and intronless splice variants) mRNA
levels from semiquantitative RT-PCR. GAPDH mRNA was used as a housekeeping control. (b) PNMT intron-retaining mRNA and (c)
intronless mRNA. Data is normalized to GAPDH control. (d) Intracellular ROS levels and (e) NO concentration after 24h. Data presented
as relative fold change or NO concentration ± SEM from a minimum of three independent experiments. Signiﬁcance deﬁned as ∗/+P<0.05;
++/##P<0.01; ∗∗∗/+++/###P<0.001.6 Oxidative Medicine and Cellular Longevity
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Figure 3: Eﬀect of ROS on the hormonal regulation of the PNMT gene. PC12 cells were treated with 200μMC o C l 2,1μM dexamethasone or
the combination of CoCl2 and dexamethasone for 24h at 37◦C. (a) Luciferase activity from cells transfected with the wild-type pGL3RP893
PNMT promoter luciferase reporter gene construct. (b) Representative image (n = 3) of PNMT (intron-retaining and intronless splice
variants) mRNA levels from semiquantitative RT-PCR. GAPDH mRNA was used as a housekeeping control. (c) PNMT intron-retaining
mRNA and (d) intronless mRNA. Data is normalized to GAPDH control. Data presented as relative fold change ± SEM from a minimum of
three independent experiments. Signiﬁcance deﬁned as ∗/+P<0.05; ++/##P<0.01; ∗∗∗/+++/###P<0.001.
and 4(d)), however, showed no further increase when treated
in combination with CoCl2.
4. Discussion
Epinephrine is found in the adrenal medulla, adrenergic
neurons, the heart, the spleen, and the liver. It is involved
in a variety of regulatory systems such as psychomotor
activity, sleep, memory and the stress response [30]. In
adrenergic cells, norepinephrine is N-methylated by the
enzyme phenylethanolamine N-methyltransferase (PNMT)
using S-adenosyl methionine as a co-substrate and a methyl
donor to form epinephrine [12]. Understanding epinephrine
production via its synthesizing enzyme PNMT is essential
to elucidating its role as a neuroendocrine regulator in
disease states [2]. Activation and regulatory mechanisms of
the PNMT gene have been studied extensively in various
systems. Recent studies demonstrate that PNMT is a stress-
responsive enzyme with stressor-speciﬁc responses [31, 32].
Hypoxic stress is one of the many stressors that can stimulate
the PNMT gene [17]. Tai et al., 2009, have previously
demonstrated that hypoxia and CoCl2 stimulate the hypoxia
inducible factor (HIF) 1α in PC12 cells to activate the PNMT
promoter and PNMT [13]. In adrenomedullary chromaﬃn
cells, trans-synaptic regulation of PNMT is mediated via
neurotransmitter release from the splanchnic nerve, whichOxidative Medicine and Cellular Longevity 7
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Figure 4: Eﬀect of ROS on the neural regulation of the PNMT gene. PC12 cells were treated with 200μMC o C l 2,1 0μM forskolin or the
combination of CoCl2 and forskolin for 24h at 37◦C. (a) Luciferase activity from cells transfected with the wild-type pGL3RP893 PNMT
promoter luciferase reporter gene construct. (b) Representative image (n = 3) of PNMT (intron-retaining and intronless splice variants)
mRNA levels from semi-quantitative RT-PCR. GAPDH mRNA was used as a housekeeping control. (c) PNMT intron-retaining mRNA and
(d) intronless mRNA. Data is normalized to GAPDH control. Data presented as relative fold change ± SEM from a minimum of three
independent experiments. Signiﬁcance deﬁned as ∗P<0.05; ∗∗/++P<0.01; +++/###P<0.001.
leads to the activation of the PNMT gene [9]. Additionally,
the biosynthesis of epinephrine in the adrenal medulla
is dependent on high concentrations of glucocorticoids
[33]. Glucocorticoids control PNMT post-translationally by
indirectly preventing the degradation of the PNMT enzyme
and by regulating the expression of PNMT mRNA [2]. The
objectives of this study were to examine and elucidate the
roles of reactive oxygen species (ROS), generated by the
hypoxia mimetic agent CoCl2 on the hormonal and neural
regulation of the PNMT gene.
ROSexertcriticalintracellularfunctions,includingsignal
transduction, gene transcription, and the regulation of
guanylate cyclase activity in cells [34]. Intracellular levels
of ROS have been demonstrated to augment during stress,
which includes hypoxia [35]. The ROS nitric oxide (NO)
is recognized as an essential intracellular messenger in the
central and peripheral nervous systems. Previous studies
have shown that NO leads to long-term upregulation of
PNMT and other catecholamine biosynthetic enzymes, and
that this is mediated by the cyclic GMP-dependent signaling
pathway [36]. As such, we examined intracellular levels of
ROS and extracellular levels of NO in PC12 cells exposed
to hypoxia or treated with CoCl2. Our ﬁndings conﬁrm
that hypoxia and CoCl2 both increase intracellular levels
of ROS and show that both treatments result in decreased
extracellular NO. This demonstrates that CoCl2 acts as a8 Oxidative Medicine and Cellular Longevity
hypoxia mimetic agent by increasing ROS in addition to
the stabilization of HIF1α and is suggestive that NO is not
involved in the induction of PNMT by CoCl2.
Treatment of cells having elevated levels of ROS with
known antioxidants, including N-acetylcysteine (NAC) and
polyphenols, has demonstrated the ability to prevent ROS-
induced responses [22]. Our ﬁndings conﬁrm the upregula-
tion of both the intronless and intron-retaining transcripts
of the PNMT gene via ROS [31]. Furthermore, decreased
intracellular levels of ROS and subsequent inhibition of
PNMT transcription were observed when cells were treated
jointly with CoCl2 and NAC. Since previous studies have
demonstrated that CoCl2 mimics hypoxia by causing the
stabilization of HIF proteins, our ﬁndings further conﬁrm
that NAC can eﬀectively abolish the HIF1α stabilization by
CoCl2, subsequently inhibiting the transcription of PNMT
[37, 38]. In an eﬀort to further elucidate the role of CoCl2-
generated ROS on PNMT activation and transcription, we
examined the combined eﬀects of CoCl2 treatment with
dexamethasone or forskolin, known hormonal and neural
activators of the PNMT promoter. Similar to previous
studies, we have demonstrated that both dexamethasone
and forskolin increase the expression of the intronless splice
variant of the PNMT gene [6, 9].
Glucocorticoids are steroid hormones released from the
adrenal cortex and are the principle eﬀectors in the stress
response [39]. Glucocorticoid sensitivity has been reported
for PNMT promoter activity in rat and bovine, and at least
one putative glucocorticoid response element (GRE) has
been identiﬁed for every species-speciﬁc PNMT gene [40].
The current study shows that PC12 cells transfected with
the full-length promoter and treated with both CoCl2 and
dexamethasone results in a synergistic eﬀect and further
drives transcription of the PNMT gene greater than the
treatment with either drug alone. This response may be
attributed to a previously reported redox mechanism in
which CoCl2 increases stabilized glucocorticoid receptor
(GR) protein within the cell [41]. Additionally, individual
studies have identiﬁed an active −282bp hypoxia response
element (HRE) and −533, −759 and −773bp GREs on
the PNMT promoter [6, 13]. We hypothesize, that it is the
combinedstimulationoftheseelementsthataregivingriseto
the observed synergistic activation of the PNMT promoter.
Moreover, increased protein levels of the transcription
factors, early growth response factor 1 (Egr-1) and speciﬁcity
protein 1 (Sp1) by HIF1α, may further drive the PNMT
promoter, giving rise to increased levels of cytoplasmic
PNMT protein [13, 19]. Although, synergistic eﬀect at the
transcriptional level is not observed, a shift from the intron-
retaining variant of PNMT to the intronless variant is
present, suggesting further post-transcriptional regulation
by CoCl2 and dexamethasone.
Previous studies have demonstrated that forskolin treat-
ment may lead to neural activation of the rat PNMT
promoter via the protein kinase A (PKA) and protein kinase
C(PKC)pathways,subsequentlyleadingtoincreasednuclear
protein levels of Egr-1 and Sp1 and increased cytoplasmic
PNMT protein [7, 42, 43]. Our ﬁndings reveal that PC12
cells transfected with the full-length promoter and treated
with both CoCl2 and forskolin results in a synergistic eﬀect
and further drives transcription of the PNMT gene greater
than treatment with either drug alone. We attribute this
response to the combination of multiple factors, mainly
stabilized GR protein by CoCl2, increased activation of the
HREbyHIF1α,andincreasedEgr-1andSp1activationofthe
PNMT promoter. While we can currently only hypothesize
on the exact mechanisms responsible for the synergistic
activation of the PNMT promoter, future overexpression
and knockdown experiments on key regulatory factors will
permit for a better understanding of PNMT regulation.
Similar to combination treatments with dexamethasone, we
show a shift from the intron-retaining variant of PNMT to
theintronlessvariantwhentreatedwithCoCl2 andforskolin.
These ﬁndings suggest post-transcriptional regulation of
PNMT by these two drugs.
Insummary,previousstudieshaveelucidatedandidenti-
ﬁed factors involved in the activation of the PNMT promoter
via the hormonal and neural pathways. Additionally, the
activation and synthesis of PNMT protein has been shown
through the upregulation of HIF1α by the hypoxia mimetic
agent CoCl2. For the ﬁrst time, our ﬁndings show that
hypoxiahassynergisticeﬀectsontheactivationofthePNMT
promoterwhencombinedwithactivationbydexamethasone
or forskolin. Furthermore, this study shows that NO is
likely not involved in the ROS-mediated transcription of the
PNMT gene and that antioxidant treatment in combination
with CoCl2 can abolish the ROS-mediated upregulation of
the PNMT gene.
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